Pune, India -- (SBWire) -- 10/24/2018 --This study researches the market size of Anti-obesity Drugs in United States, European Union and China, presents the Anti-obesity Drugs sales, revenue, market share and growth rate by companies, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
PDF Sample For In-depth Analysis and Forecast - https://www.qyresearch.com/sample-form/form/836339/global-united-states-european-union-and-china-anti-obesity-drugs-market
In 2018, the market size of Anti-obesity Drugs is xx million US$ and it will reach xx million US in 2025, growing at a CAGR of xx% from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period.
In this report, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Anti-obesity Drugs.
In United States, European Union and China market, the following companies are covered:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segment by Product Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segment by Application
Kids
Adults
Key Regions split in this report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Browse report Details with Complete ToC- https://www.qyresearch.com/index/detail/836339/global-united-states-european-union-and-china-anti-obesity-drugs-market
The study objectives are:
To analyze and research the Anti-obesity Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-obesity Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-obesity Drugs are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Anti-Obesity Drugs Market : Key Players Eyeing to Penetrate Into Emerging Nations with Untapped Opportunities
Global (United States, European Union and China) Anti-obesity Drugs Market Research Report 2018-2025